Showing results (1-10 of 706) with videos related to

Sort By:
Pageof 71
European Urology|July 27, 2026
Cystectomy Can Be Spared in Selected Patients with Muscle-invasive Bladder Cancer and Complete Response Following Neoadjuvant TherapyMatthew D Galsky, Andrea Necchi
Cancer|May 13, 2022
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoringAlberto Martini, Menggang Yu, Daniele Raggi, et al.
European Urology|October 27, 2015
The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysisPatrizia Giannatempo, Gregory R Pond, Guru Sonpavde, et al.
European Urology Oncology|November 12, 2020
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the BladderMathieu Rouanne, Dean F Bajorin, Raquibul Hannan, et al.
The Oncologist|November 30, 2005
The role of taxanes in the management of bladder cancerMatthew D Galsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
New developments in urothelial cancerMatthew D Galsky
Urologic Oncology|April 15, 2020
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinomaAlberto Martini, Ugo Giovanni Falagario, Nikhil Waingankar, et al.
Journal of Geriatric Oncology|December 9, 2014
How I treat bladder cancer in elderly patientsMatthew D Galsky
Clinical Genitourinary Cancer|June 22, 2016
Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-AnalysisAndrea Necchi, Gregory R Pond, Daniele Raggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275Matthew D Galsky, Abdel Saci, Peter M Szabo, et al.
Pageof 71